Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Endocrine Development|May 10, 2005
Insulin resistance and type 2 diabetes mellitus: is there a therapeutic role for IGF-1?Alan C Moses
American Journal of Preventive Medicine|March 19, 2013
Diabetes prevention: perspectives and actions of one companyAlan C Moses, Michael Mawby, Anne M Phillips
The Journal of Clinical Endocrinology and Metabolism|January 7, 2011
GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutideLaszlo Hegedüs, Alan C Moses, Milan Zdravkovic, et al.
Therapeutic Innovation & Regulatory Science|May 26, 2018
Developing, Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)Hanne Theilgaard, Inger Mollerup, Ida Carøe Helmark, et al.
Diabetes Care|October 30, 2019
Redefining Hypoglycemia in Clinical Trials: Validation of Definitions Recently Adopted by the American Diabetes Association/European Association for the Study of DiabetesSimon R Heller, John B Buse, Robert Ratner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2005
Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2 x 2 factorial, randomized, double-blinded, placebo-controlled trialAlina Gavrila, William Hsu, Sotirios Tsiodras, et al.
Endocrine Pathology|October 1, 1995
Insulin-Like Growth Factor I in Human Thyroid Tissue: Specific Localization by Immunohistochemistry and In Situ HybridizationRui M. B. Maciel, Edna T. Kimura, Mirian H. Takahaski, et al.
Diabetes, Obesity & Metabolism|April 7, 2020
Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTESimon Heller, Ildiko Lingvay, Steven P Marso, et al.
Diabetes, Obesity & Metabolism|September 30, 2020
Development of a hypoglycaemia risk score to identify high-risk individuals with advanced type 2 diabetes in DEVOTESimon Heller, Ildiko Lingvay, Steven P Marso, et al.
Diabetes, Obesity & Metabolism|February 23, 2019
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)Kirstine Brown-Frandsen, Scott S Emerson, Darren K McGuire, et al.
Pageof 2